Janus Henderson Group PLC Coherus Bio Sciences, Inc. Transaction History

Janus Henderson Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $28 - $69	18 Added 0.07%	26,496 $88,000
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $321 - $468	86 Added 0.33%	26,478 $99,000
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $102 - $224	-27 Reduced 0.1%	26,392 $112,000
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $85,363 - $152,466	14,493 Added 121.52%	26,419 $180,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $57 - $110	8 Added 0.07%	11,926 $114,000
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $5 - $13	1 Added 0.01%	11,918 $86,000
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $21 - $32	2 Added 0.02%	11,917 $154,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $188,376 - $226,265	11,915 New	11,915 $190,000
Q3 2021 Nov 16, 2021	SELL	$12.68 - $17.79 $243,760 - $341,994	-19,224 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $5,840 - $6,949	451 Added 2.4%	19,224 $266,000
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $7.03 Million - $10.4 Million	-487,276 Reduced 96.29%	18,773 $274,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $16.9 Million - $19.3 Million	-1,018,538 Reduced 66.81%	506,049 $8.8 Million
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $11.3 Million - $12.9 Million	649,603 Added 74.24%	1,524,587 $28 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $12.6 Million - $16.8 Million	874,984 New	874,984 $15.6 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.